earnings
confidence high
sentiment positive
materiality 0.70
Nuwellis Q2 revenue up 6% to $2.2M; gross margin expands to 67.2%
Nuwellis, Inc.
2024-Q2 EPS reported
-$40.91
revenue$4,051,000
- Revenue $2.2M (+6% YoY); Critical Care revenue up 28%, Heart Failure consumables utilization up 35%.
- Gross margin 67.2% vs 55.3% prior year; total operating expenses down 38% to $3.8M.
- Net loss $7.7M vs $4.8M; basic EPS loss $18.85 vs $127.65 (improved due to share count changes).
- Cash and equivalents $1.0M; no debt; closed registered direct offering for $2.0M gross proceeds on July 25.
- Expanded Aquadex to pediatric patients in Florida hospital network; signed purchase agreement with 50-hospital Texas network.